Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Short-Term Debt repayments (2021)

Terns Pharmaceuticals (TERN) has disclosed Short-Term Debt repayments for 1 consecutive years, with $12.9 million as the latest value for Q1 2021.

  • For the quarter ending Q1 2021, Short-Term Debt repayments changed N/A year-over-year to $12.9 million, compared with a TTM value of $12.9 million through Dec 2021, changed N/A, and an annual FY2021 reading of $12.9 million, changed N/A over the prior year.
  • Short-Term Debt repayments was $12.9 million for Q1 2021 at Terns Pharmaceuticals.
  • Across five years, Short-Term Debt repayments topped out at $12.9 million in Q1 2021 and bottomed at $12.9 million in Q1 2021.